BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26971586)

  • 1. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.
    Galtier M; De Sordi L; Maura D; Arachchi H; Volant S; Dillies MA; Debarbieux L
    Environ Microbiol; 2016 Jul; 18(7):2237-45. PubMed ID: 26971586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro.
    Freitag T; Squires RA; Schmid J
    Res Vet Sci; 2008 Aug; 85(1):1-7. PubMed ID: 17959211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine.
    Maura D; Galtier M; Le Bouguénec C; Debarbieux L
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6235-42. PubMed ID: 23006754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Dynamics of
    Porse A; Gumpert H; Kubicek-Sutherland JZ; Karami N; Adlerberth I; Wold AE; Andersson DI; Sommer MOA
    Front Cell Infect Microbiol; 2017; 7():126. PubMed ID: 28447026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperimmune bovine colostrum reduces gastrointestinal carriage of uropathogenic Escherichia coli.
    Larcombe S; Hutton ML; Lyras D
    Hum Vaccin Immunother; 2019; 15(2):508-513. PubMed ID: 30277834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
    Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
    Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between virulence profile, biofilm formation and phylogenetic groups of Escherichia coli causing urinary tract infection and the commensal gut microbiota: A comparative analysis.
    Hashemizadeh Z; Kalantar-Neyestanaki D; Mansouri S
    Microb Pathog; 2017 Sep; 110():540-545. PubMed ID: 28760455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics.
    Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC
    J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.
    Dufour N; Debarbieux L; Fromentin M; Ricard JD
    Crit Care Med; 2015 Jun; 43(6):e190-8. PubMed ID: 25803649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.
    Pourbaix A; Guérin F; Lastours V; Chau F; Auzou M; Boulley E; Cattoir V; Fantin B
    Int J Med Microbiol; 2017 Dec; 307(8):452-459. PubMed ID: 28986014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci.
    Dang TN; Zhang L; Zöllner S; Srinivasan U; Abbas K; Marrs CF; Foxman B
    Infect Genet Evol; 2013 Oct; 19():212-8. PubMed ID: 23891665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Payload hardware and experimental protocol development to enable future testing of the effect of space microgravity on the resistance to gentamicin of uropathogenic Escherichia coli and its σ
    Matin AC; Wang JH; Keyhan M; Singh R; Benoit M; Parra MP; Padgen MR; Ricco AJ; Chin M; Friedericks CR; Chinn TN; Cohen A; Henschke MB; Snyder TV; Lera MP; Ross SS; Mayberry CM; Choi S; Wu DT; Tan MX; Boone TD; Beasley CC; Piccini ME; Spremo SM
    Life Sci Space Res (Amst); 2017 Nov; 15():1-10. PubMed ID: 29198308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
    Blango MG; Mulvey MA
    Antimicrob Agents Chemother; 2010 May; 54(5):1855-63. PubMed ID: 20231390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine.
    Liu SW; Xu XY; Xu J; Yuan JY; Wu WK; Zhang N; Chen ZL
    Chin J Integr Med; 2017 Oct; 23(10):763-769. PubMed ID: 28028717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.